{"latest_checked": "2026-08-13T04:33:12.746470+00:00", "coverage_count": 5070, "recent_count": 52, "transaction_limit": 160, "filters": {"q": "", "ticker": "TLRY", "sector": "", "industry": "", "side": "", "start": "2026-06-30", "end": "2026-08-14"}, "summary": {"total": 52, "acquisition_count": 27, "disposal_count": 25, "acquisition_value": 69225.0, "acquisition_value_label": "$69.2K", "disposal_value": 2080356.39, "disposal_value_label": "$2.1M", "net_value": -2011131.39, "net_value_label": "$-2.0M", "flow_tone": "negative", "largest_value_label": "$906.0K", "top_sector": "Healthcare", "window_label": "30 Jun 2026 to 14 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 52, "value": "2149581.3900", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$2.1M"}], "days": [{"transaction_date": "2026-07-29", "acquisitions": 17, "disposals": 17, "total": 34, "bar_width": 100.0}, {"transaction_date": "2026-07-30", "acquisitions": 7, "disposals": 8, "total": 15, "bar_width": 44.1}, {"transaction_date": "2026-08-03", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 2.9}, {"transaction_date": "2026-08-04", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 2.9}, {"transaction_date": "2026-08-06", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 2.9}], "side_mix": {"acquisitions": 27, "disposals": 25, "acquisition_share": 51.9, "disposal_share": 48.1}}, "company_flows": [{"symbol": "TLRY", "name": "Tilray Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-08-06", "acquisitions": 3, "disposals": 11, "acquired_value": 69225.0, "acquired_value_label": "$69.2K", "disposed_value": 2080356.39, "disposed_value_label": "$2.1M", "net_value": -2011131.39, "net_value_label": "$-2.0M", "acquisition_share": 21.4, "disposal_share": 78.6, "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}], "company_overview": [{"symbol": "TLRY", "name": "Tilray Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-08-06", "filings": 52, "acquisitions": 27, "disposals": 25, "acquired_value": 69225.0, "acquired_value_label": "$69.2K", "disposed_value": 2080356.39, "disposed_value_label": "$2.1M", "net_value": -2011131.39, "net_value_label": "$-2.0M", "acquisition_share": 51.9, "disposal_share": 48.1, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}], "transactions": [{"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-08-06", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2500.0, "share_price": 4.43, "transaction_value": 11075.0, "transaction_value_label": "$11.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.236802+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-08-04", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 4.62, "transaction_value": 46200.0, "transaction_value_label": "$46.2K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.240092+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-08-03", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2500.0, "share_price": 4.78, "transaction_value": 11950.0, "transaction_value_label": "$11.9K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.241911+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 26120.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.265434+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 26120.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.245418+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 24379.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.249634+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 24379.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.259339+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "HERHALT, JOHANN MICHAEL", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 62657.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.267375+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "HOPKINSON, DAVID G.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 62657.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.261424+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "LOONEY, THOMAS P.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 62657.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.251640+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 16656.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.255775+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 16656.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.271132+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "SIMON, IRWIN D", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 117647.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.257552+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "SIMON, IRWIN D", "executive_title": "Director, President and CEO", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 117647.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.269252+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "SIMON, IRWIN D", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 62353.0, "share_price": 4.2, "transaction_value": 261882.6, "transaction_value_label": "$261.9K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.263413+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 13844.0, "share_price": 4.2, "transaction_value": 58144.8, "transaction_value_label": "$58.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.243494+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 12921.0, "share_price": 4.2, "transaction_value": 54268.2, "transaction_value_label": "$54.3K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.253602+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-30", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 9161.0, "share_price": 4.2, "transaction_value": 38476.2, "transaction_value_label": "$38.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.247491+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "CLANACHAN, DAVID F", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.297913+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "CLANACHAN, DAVID F", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.307522+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "CLANACHAN, DAVID F", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 62657.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.301620+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "COHEN, STEVEN MICHAEL", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.294276+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "COHEN, STEVEN MICHAEL", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 62657.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.296087+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "COHEN, STEVEN MICHAEL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.292526+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 281901.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.323542+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 93685.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.329803+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 93685.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.321788+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 87440.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.333521+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 263108.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.331681+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 87440.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.275014+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "HERHALT, JOHANN MICHAEL", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.290533+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "HERHALT, JOHANN MICHAEL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.286434+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "HOPKINSON, DAVID G.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.305524+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "HOPKINSON, DAVID G.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.303507+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "LOONEY, THOMAS P.", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.283375+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "LOONEY, THOMAS P.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.317492+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 60417.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.339688+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 180302.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.313520+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 60417.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.311544+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "PERSOFSKY, RENAH", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.276910+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "PERSOFSKY, RENAH", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 62657.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.315505+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "PERSOFSKY, RENAH", "executive_title": "Director", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 43104.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.281311+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "SIMON, IRWIN D", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 428448.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.327752+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "SIMON, IRWIN D", "executive_title": "Director, President and CEO", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 428448.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.309481+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "SIMON, IRWIN D", "executive_title": "Director, President and CEO", "security_type": "Restricted Stock Units", "side_code": "A", "side": "Acquisition", "shares": 1289211.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-13T03:36:12.272949+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "SIMON, IRWIN D", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 227078.0, "share_price": 3.99, "transaction_value": 906041.22, "transaction_value_label": "$906.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.325581+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "FALTISCHEK, DENISE M", "executive_title": "Chief Strategy Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 49654.0, "share_price": 3.99, "transaction_value": 198119.46, "transaction_value_label": "$198.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.319608+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "GENDEL, MITCHELL", "executive_title": "Global General Counsel", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 46344.0, "share_price": 3.99, "transaction_value": 184912.56, "transaction_value_label": "$184.9K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.335356+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "MERTON, CARL A", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 30209.0, "share_price": 3.99, "transaction_value": 120533.91, "transaction_value_label": "$120.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.337505+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "CLANACHAN, DAVID F", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 21552.0, "share_price": 3.99, "transaction_value": 85992.48, "transaction_value_label": "$86.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.299723+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "HERHALT, JOHANN MICHAEL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 21552.0, "share_price": 3.99, "transaction_value": 85992.48, "transaction_value_label": "$86.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.288482+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}, {"symbol": "TLRY", "name": "Tilray Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-29", "executive": "PERSOFSKY, RENAH", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 21552.0, "share_price": 3.99, "transaction_value": 85992.48, "transaction_value_label": "$86.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T03:36:12.279099+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tlry/", "research_links": {"chart": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/", "report": "/terminal/c8501ac1-4a03-4ea7-baa2-2d4774317750/report/", "factor": "/factors/ticker/c8501ac1-4a03-4ea7-baa2-2d4774317750/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}